Generalized morphea after COVID-19 vaccines: a case series.

Paolino, G; Campochiaro, C; Di Nicola, M R; Mercuri, S R; Rizzo, N; Dagna, L; Rongioletti, F; De Luca, G

Paolino, G; Campochiaro, C; Di Nicola, M R; Mercuri, S R; Rizzo, N; Dagna, L; Rongioletti, F; De Luca, G.

Afiliação

Paolino G; Unità di Dermatologia Clinica, Vita-Salute San Raffaele University, Milan, Italy.
Campochiaro C; Unit of Dermatology and Cosmetology, IRCCS San Raffaele Hospital, Milan, Italy.
Di Nicola MR; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milan, Italy.
Mercuri SR; Unit of Dermatology and Cosmetology, IRCCS San Raffaele Hospital, Milan, Italy.
Rizzo N; Unit of Dermatology and Cosmetology, IRCCS San Raffaele Hospital, Milan, Italy.
Dagna L; Surgical Pathology, IRCCS San Raffaele Hospital, Milan, Italy.
Rongioletti F; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milan, Italy.
De Luca G; Vita-Salute San Raffaele University, Milan, Italy.

J Eur Acad Dermatol Venereol ; 36(9): e680-e682, 2022 09.

Article em En | MEDLINE | ID: mdl-35604052

Assuntos

COVID-19; Esclerodermia Localizada; Escleroderma Sistêmico; Vacinas contra COVID-19/efeitos adversos; Humanos; Esclerodermia Localizada/etiologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerodermia Localizada / Escleroderma Sistêmico / COVID-19 Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Revista: J Eur Acad Dermatol Venereol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google